Status:
COMPLETED
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
Lead Sponsor:
University Hospital, Motol
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the quality of...
Detailed Description
In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the quality o...
Eligibility Criteria
Inclusion
- Patients post alcohol septal ablation
- Pressure gradient in left ventricular outflow tract \<30 mmHg
- Written consent to participate
Exclusion
- History of atrial fibrillation
- Symptoms of Class III or IV of New York Heart Association functional classification
- Permanent pacemaker implant
- Age above 75
Key Trial Info
Start Date :
March 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04133532
Start Date
March 5 2020
End Date
February 23 2023
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Motol University Hospital
Prague, Czech Republic, Czechia, 15000